Nagata S, Hyde C C, Miles E W
Section on Pharmacology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
J Biol Chem. 1989 Apr 15;264(11):6288-96.
Our studies, which are aimed at understanding the catalytic mechanism of the alpha subunit of tryptophan synthase from Salmonella typhimurium, use site-directed mutagenesis to explore the functional roles of aspartic acid 60, tyrosine 175, and glycine 211. These residues are located close to the substrate binding site of the alpha subunit in the three-dimensional structure of the tryptophan synthase alpha 2 beta 2 complex. Our finding that replacement of aspartic acid 60 by asparagine, alanine, or tyrosine results in complete loss of activity in the reaction catalyzed by the alpha subunit supports a catalytic role for aspartic acid 60. Since the mutant form with glutamic acid at position 60 has partial activity, glutamic acid 60 may serve as an alternative catalytic base. The mutant form in which tyrosine 175 is replaced by phenylalanine has substantial activity; thus the phenolic hydroxyl of tyrosine 175 is not essential for catalysis or substrate binding. Yanofsky and colleagues have identified many missense mutant forms of the alpha subunit of tryptophan synthase from Escherichia coli. Two of these inactive mutant forms had either tyrosine 175 replaced by cysteine or glycine 211 replaced by glutamic acid. Surprisingly, a second-site revertant which contained both of these amino acid changes was partially active. These results indicated that the second mutation must compensate in some way for the first. We now extend the studies of the effects of specific amino acid replacements at positions 175 and 211 by two techniques: 1) characterization of several mutant forms of the alpha subunit from S. typhimurium prepared by site-directed mutagenesis and 2) computer graphics modeling of the substrate binding site of the alpha subunit using the x-ray coordinates of the wild type alpha 2 beta 2 complex from S. typhimurium. We conclude that the restoration of alpha subunit activity in the doubly altered second-site revertant results from restoration of the proper geometry of the substrate binding site.
我们的研究旨在了解鼠伤寒沙门氏菌色氨酸合成酶α亚基的催化机制,采用定点突变技术来探究天冬氨酸60、酪氨酸175和甘氨酸211的功能作用。在色氨酸合成酶α2β2复合物的三维结构中,这些残基位于α亚基的底物结合位点附近。我们发现,用天冬酰胺、丙氨酸或酪氨酸取代天冬氨酸60会导致α亚基催化的反应完全丧失活性,这支持了天冬氨酸60的催化作用。由于60位为谷氨酸的突变体形式具有部分活性,因此谷氨酸60可能作为替代催化碱基。酪氨酸175被苯丙氨酸取代的突变体形式具有相当的活性;因此,酪氨酸175的酚羟基对于催化或底物结合并非必不可少。亚诺夫斯基及其同事鉴定出了许多大肠杆菌色氨酸合成酶α亚基的错义突变体形式。其中两种无活性的突变体形式要么是酪氨酸175被半胱氨酸取代,要么是甘氨酸211被谷氨酸取代。令人惊讶的是,包含这两种氨基酸变化的第二位点回复突变体具有部分活性。这些结果表明,第二次突变必定以某种方式补偿了第一次突变。我们现在通过两种技术扩展对175位和211位特定氨基酸取代效应的研究:1)对通过定点突变制备的鼠伤寒沙门氏菌α亚基的几种突变体形式进行表征,2)利用鼠伤寒沙门氏菌野生型α2β2复合物的X射线坐标对α亚基的底物结合位点进行计算机图形建模。我们得出结论,双重改变的第二位点回复突变体中α亚基活性的恢复是由于底物结合位点正确几何结构的恢复。